Sonic Healthcare Ltd
SHL: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$99.00 | Tqrbmff | Dsfhmrc |
Sonic Healthcare's Earnings to Retrace From Coronavirus-Elevated Levels From Fiscal 2022 Onward
Business Strategy and Outlook
Sonic’s “medical leadership” model recognises the importance of the relationship with the referring doctor as the company seeks to differentiate itself on service levels rather than purely price. Evidence of the success of the model is the organic growth rate ahead of the market, suggesting market share gains. In an industry where absolute volumes are an important component in achieving cost advantage, Sonic’s source of moat, the organic growth supplemented by acquisitions continues to add value for shareholders.